Valued at $1.25 billion, the deal expands BioNTech’s cancer drug portfolio and heads off royalty costs it could have owed ...

said on Wednesday it has achieved a "final victory" in a patent invalidation case against Moderna, the global developer of the messenger-RNA (mRNA) COVID-19 vaccine. SK bioscience filed a nullity ...

Moderna, Inc.'s stock surged 16% yesterday after a German court ruled Pfizer and BioNTech may have violated Moderna's COVID-19 vaccine patent, potentially leading to compensation. Despite the ...

The lawsuits add to a web of U.S. court cases involving Pfizer, BioNTech and Moderna over patent royalties for technology used in their COVID vaccines ... over its RSV shot Abrysvo last year.

Moderna Inc. scored a partial ... made by Pfizer Inc and BioNTech SE selling Covid-19 vaccine, after a London judge ruled that one of its two patents was valid. Pfizer and and its German partner ...

Moderna said on May 17 that the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing Covid-19 vaccine dispute with Pfizer and BioNTech.

London: Moderna has won a case ... COVID shot Comirnaty since it sued them in 2022 for allegedly copying its mRNA technology. Pfizer and BioNTech have also countersued, alleging that Moderna's ...

Moderna said Friday that the European Patent ... rival COVID-19 vaccines. Cambridge-based Moderna has been fighting Pfizer and BioNTech in the courts over the partners’ COVID shot, called ...

May 17 (Reuters) - Moderna (MRNA.O), opens new tab said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine ...

Moderna MRNA-Q said on Friday the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer PFE-N and BioNTech ...

(Reuters) -Moderna ... patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer and BioNTech. The company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot ...